Lu Wang
11Patents
7h-index
74Co-inventors
65Inventor score
Filing activity: Apr 2, 2007 → Nov 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8008481B2 | Indazole compounds | Chemistry; Metallurgy | 107 | Active |
| US8785639B2 | Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof | Chemistry; Metallurgy | 57 | Active |
| US8962629B2 | Tricyclic compounds | Chemistry; Metallurgy | 54 | Active |
| US9365579B2 | Tricyclic compounds | Chemistry; Metallurgy | 49 | Active |
| US8648069B2 | 5-substituted indazoles as kinase inhibitors | Chemistry; Metallurgy | 41 | Active |
| US8754107B2 | Aminopyrrolidines as chemokine receptor antagonists | Chemistry; Metallurgy | 23 | Active |
| US9163007B2 | 5-substituted indazoles as kinase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US8598199B2 | Octahydropentalene compounds as chemokine receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US7939544B2 | Octahydropentalene compounds as chemokine receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US9567339B2 | Primary carboxamides as BTK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10772970B2 | Glucocorticoid receptor agonist and immunoconjugates thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.